Modeling antibiotic resistance in hospitals: The impact of minimizing treatment duration

被引:118
作者
D'Agata, Erika M. C. [1 ]
Magal, Pierre [2 ]
Olivier, Damien [3 ]
Ruan, Shigui [4 ]
Webb, Glenn F. [5 ]
机构
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Univ Havre, Dept Math, F-76058 Le Havre, France
[3] Univ Havre, Dept Comp Sci, F-76058 Le Havre, France
[4] Univ Miami, Dept Math, Coral Gables, FL 33124 USA
[5] Vanderbilt Univ, Dept Math, Nashville, TN 37240 USA
关键词
antibiotic-resistant bacteria; individual-based model; differential equation model; basic reproduction number;
D O I
10.1016/j.jtbi.2007.08.011
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Infections caused by antibiotic-resistant pathogens are a global public health problem. Numerous individual- and population-level factors contribute to the emergence and spread of these pathogens. An individual-based model (IBM), formulated as a system of stochastically determined events, was developed to describe the complexities of the transmission dynamics of antibiotic-resistant bacteria. To simplify the interpretation and application of the model's conclusions, a corresponding deterministic model was created, which describes the average behavior of the IBM over a large number of simulations. The integration of these two model systems provides a quantitative analysis of the emergence and spread of antibiotic-resistant bacteria, and demonstrates that early initiation of treatment and minimization of its duration mitigates antibiotic resistance epidemics in hospitals. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:487 / 499
页数:13
相关论文
共 36 条
[1]  
ANDERSON R M, 1991
[2]   Vancomycin-resistant enterococci in intensive-care hospital settings: Transmission dynamics, persistence, and the impact of infection control programs [J].
Austin, DJ ;
Bonten, MJM ;
Weinstein, RA ;
Slaughter, S ;
Anderson, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6908-6913
[3]   Cultural and economic factors that (Mis)Shape antibiotic use: The nonpharmacologic basis of therapeutics [J].
Avorn, J ;
Solomon, DH .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (02) :128-135
[4]   Evaluating treatment protocols to prevent antibiotic resistance [J].
Bonhoeffer, S ;
Lipsitch, M ;
Levin, BR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (22) :12106-12111
[5]  
Bonten M J, 2001, Lancet Infect Dis, V1, P314, DOI 10.1016/S1473-3099(01)00145-1
[6]   Controlling methicillin-resistant Staphylococcus aureus:: Quantifying the effects of interventions and rapid diagnostic testing [J].
Bootsma, MCJ ;
Diekmann, O ;
Bonten, MJM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (14) :5620-5625
[7]  
Brauer F., 2000, MATH MODELS POPULATI
[8]   Infection control - A problem for patient safety [J].
Burke, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07) :651-656
[9]   Metaanalysis of short course antibiotic treatment for group a streptococcal tonsillopharyngitis [J].
Casey, JR ;
Pichichero, ME .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (10) :909-917
[10]   Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults - A randomized trial [J].
Chastre, J ;
Wolff, M ;
Fagon, JY ;
Chevret, S ;
Thomas, F ;
Wermert, D ;
Clementi, E ;
Gonzalez, J ;
Jusserand, D ;
Asfar, P ;
Perrin, D ;
Fieux, F ;
Aubas, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (19) :2588-2598